Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000243

EVP, Chief Business Officer sold 15,000 shares at $68.01 ($1,020,210)

  • EVP, Chief Business Officer acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-02 Exercise or conversion : show line 1 in the form 10b5-1 +15,000 $31.80 $477,000 46,926 D
2025-10-02 Sale : show line 2 in the form 10b5-1 −15,000 $68.01 $1,020,210 31,926 D
Open-market sales · 15,000 sh · avg $68.01 · $1,020,210

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-02 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −15,000 26,700 D
Loading xslF345X05/edgardoc.xml…